Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Octapharma Ag

Home Clinical Trial Sponsors and OrganizationsOctapharma Ag

Octapharma Ag

ACTIVE

Costa RicaoctapharmaagPrivate10,001+ employeesEstablished: 1983-01-01

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

122

112 active

Approvals

12

Total approvals

Agencies

1

Regulatory bodies

Founded

1983

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 1

52

42.6%

Phase 3

13

10.7%

Phase 2

2

1.6%

Not Applicable

1

0.8%

Phase 4

1

0.8%

Trial Status Distribution

Active, not recruiting

112

91.8%

Completed

6

4.9%

Recruiting

2

1.6%

Suspended

2

1.6%

Clinical Trials

Trials sponsored by this organization (122)

Phase 3 Study on the Efficacy and Safety of Human Plasma Derived Antithrombin (Atenativ) in Heparin-resistant Patients Scheduled to Undergo Cardiac Surgery Necessitating Cardiopulmonary Bypass

Active, not recruiting

Apr 2024120 participants

uwiq Dosing and outcomes In the ManagEment of women/girls with haemophilia A Needing FVIII treatment for Surgery – an International, Open-label, Non-controlled study (NuDIMENSION)

Active, not recruiting

Jan 202322 participants

uwiq for Perioperative management Of patients With haemophilia A on Emicizumab Regular prophylaxis study (NuPOWER)

Active, not recruiting

Jan 202350 participants

Study to demonstrate the efficacy and safety of OCTAPLEX in patients with acute major bleeding that are taking direct oral anticoagulant.

Active, not recruiting

Nov 2022260 participants

Efficacy of Atenativ in Patients With Congenital Antithrombin Deficiency Undergoing Surgery or Delivery

Active, not recruiting

Mar 202234 participants

Efficacy of Atenativ in Patients With Congenital Antithrombin Deficiency Undergoing Surgery or Delivery

Active, not recruiting

Feb 202238 participants

Efficacy of Atenativ in Patients With Congenital Antithrombin Deficiency Undergoing Surgery or Delivery

Active, not recruiting

Jan 202234 participants

Efficacy of Atenativ in Patients With Congenital Antithrombin Deficiency Undergoing Surgery or Delivery

Active, not recruiting

Jan 202238 participants

Page 1 of 16

Approvals

Approvals by Agency

SFDA

Saudi Food and Drug Authority

12

Approvals

Recent Approvals

WILATE 500 IU Powder and Solvent for Solution for Injection

OCTAPLAS LG 45-70MG/ML

News

No news articles found

On this page

Overview
Clinical Trials122
Approvals12
News

Back to Organizations